CHENNAI, India, June 20, 2025 /PRNewswire/ — At ACMEE 2025, one of South India’s most prominent exhibitions for machine tools and automation, HSG Laser showcased a strong portfolio of smart manufacturing solutions. The company’s presence reflects not only its technological strength but also its growing impact in the Indian market, where it has been ranked the No.1 laser equipment brand for three consecutive years (2023–2025).
At Booth D18, HSG Laser showcased a trio of high-end laser systems designed to meet the demands of industrial manufacturers pursuing higher productivity, precision, and smart automation.
Expanding Local Service Capabilities
HSG Laser has been active in the Indian market since 2012, and its growth is underpinned by a long-term localization strategy. Today, 90% of its Indian team is composed of local professionals, reflecting the company’s commitment to regional development and talent cultivation.
In 2025, HSG has accelerated the expansion of its local service infrastructure, including:
“We see localization not just as a business strategy, but as a long-term responsibility,” said a spokesperson for HSG’s global operations. “Our goal is to empower customers through reliable technology, supported by fast, local service.”
Global Innovation, Local Execution
HSG’s presence at ACMEE 2025 marks another step in its global roadmap—delivering intelligent, efficient, and sustainable metalworking solutions tailored to local markets. As the company deepens its roots in India, it continues to balance world-class innovation with real-world customer needs, setting a benchmark for international players in the metal processing industry.
View original content:https://www.prnewswire.com/in/news-releases/hsg-laser-named-indias-top-laser-equipment-brand-for-third-consecutive-year-strengthens-local-commitment-at-acmee-2025-302486843.html
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…